Researcher Sounded Alarm on Medtronic's Infuse Years Ago
As part of a continuing investigation into a bone morphogenetic protein-2 product marketed as Infuse, the Milwaukee Journal Sentinel/ֱ describe a first-hand account of early signs of problems with the device as well as efforts to minimize the clinical significance of those problems.
Jun 28, 2011